{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T20:25:11Z","timestamp":1776975911695,"version":"3.51.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T00:00:00Z","timestamp":1529020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T00:00:00Z","timestamp":1529020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007238","name":"Office of Women\u2019s Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Sex Differ"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13293-018-0183-9","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T04:18:04Z","timestamp":1529036284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Doxorubicin-induced cardiotoxicity is suppressed by estrous-staged treatment and exogenous 17\u03b2-estradiol in female tumor-bearing spontaneously hypertensive rats"],"prefix":"10.1186","volume":"9","author":[{"given":"Kaytee L.","family":"Pokrzywinski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas G.","family":"Biel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot T.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia L.","family":"Bonanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baikuntha","family":"Aryal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Mascia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delaram","family":"Moshkelani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Mog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. Ashutosh","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,15]]},"reference":[{"key":"183_CR1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/cdd.2014.150","volume":"22","author":"DDZ G Filomeni","year":"2015","unstructured":"G Filomeni DDZ, Cecconi F. Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death Differ. 2015;22:377\u201388.","journal-title":"Cell Death Differ"},{"key":"183_CR2","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","volume":"52","author":"YTC Octavia","year":"2012","unstructured":"Octavia YTC, Gabrielson KL, Janssens S, Crijns HJ, Moens AL. Doxorubicin-induced cardiomyopathy. J Mol Cell Cardiol. 2012;52:1213\u201325.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"183_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/med.21280","volume":"34","author":"FS Carvalho","year":"2014","unstructured":"Carvalho FS, Burgeiro A, Garcia R, Moreno AJ, Carvalho RA, Oliveira PJ. Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy. Med Res Rev. 2014;34(1):106\u201335.","journal-title":"Med Res Rev"},{"issue":"3","key":"183_CR4","first-page":"424","volume":"39","author":"S Kumar","year":"2012","unstructured":"Kumar S, Marfatia R, Tannenbaum S, Yang C, Avelar E. Doxorubicin-induced cardiomyopathy 17 years after chemotherapy. Tex Heart Inst J. 2012;39(3):424\u20137.","journal-title":"Tex Heart Inst J"},{"issue":"2","key":"183_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s11764-014-0408-9","volume":"9","author":"A Qin","year":"2015","unstructured":"Qin A, Thompson CL, Silverman P. Predictors of late-onset heart failure in breast cancer patients treated with doxorubicin. J Cancer Surviv. 2015;9(2):252\u20139.","journal-title":"J Cancer Surviv"},{"issue":"12","key":"183_CR6","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1200\/JCO.1996.14.12.3112","volume":"14","author":"M Venturini","year":"1996","unstructured":"Venturini M, Michelotti A, Del Mastro L, Gallo L, Carnino F, Garrone O, Tibaldi C, Molea N, Bellina RC, Pronzato P, et al. Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer. J Clin Oncol. 1996;14(12):3112\u201320.","journal-title":"J Clin Oncol"},{"issue":"2","key":"183_CR7","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1172\/JCI72931","volume":"124","author":"Y Ichikawa","year":"2014","unstructured":"Ichikawa Y, Ghanefar M, Bayeva M, Wu R, Khechaduri A, Naga Prasad SV, Mutharasan RK, Naik TJ, Ardehali H. Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. J Clin Invest. 2014;124(2):617\u201330.","journal-title":"J Clin Invest"},{"issue":"2","key":"183_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12012-007-0020-6","volume":"7","author":"H Kaiserova","year":"2007","unstructured":"Kaiserova H, Simunek T, Sterba M, den Hartog GJ, Schroterova L, Popelova O, Gersl V, Kvasnickova E, Bast A. New iron chelators in anthracycline-induced cardiotoxicity. Cardiovasc Toxicol. 2007;7(2):145\u201350.","journal-title":"Cardiovasc Toxicol"},{"key":"183_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ejphar.2017.10.043","volume":"818","author":"K Renu","year":"2018","unstructured":"Renu K, Abilash VG, Pichiah P, Arunachalam S. Molecular mechanism of doxorubicin-induced cardiomyopathy\u2014an update. Eur J Pharmacol. 2018;818:241\u201353.","journal-title":"Eur J Pharmacol"},{"issue":"7 Pt B","key":"183_CR10","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/j.bbamcr.2016.01.021","volume":"1863","author":"A Ghigo","year":"2016","unstructured":"Ghigo A, Li M, Hirsch E. New signal transduction paradigms in anthracycline-induced cardiotoxicity. Biochim Biophys Acta. 2016;1863(7 Pt B):1916\u201325.","journal-title":"Biochim Biophys Acta"},{"issue":"19","key":"183_CR11","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1200\/JCO.2007.14.1242","volume":"26","author":"DL Hershman","year":"2008","unstructured":"Hershman DL, McBride RB, Eisenberger A, Tsai WY, Grann VR, Jacobson JS. Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin\u2019s lymphoma. J Clin Oncol. 2008;26(19):3159\u201365.","journal-title":"J Clin Oncol"},{"issue":"1","key":"183_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.taap.2013.08.012","volume":"273","author":"LC Sharkey","year":"2013","unstructured":"Sharkey LC, Radin MJ, Heller L, Rogers LK, Tobias A, Matise I, Wang Q, Apple FS, McCune SA. Differential cardiotoxicity in response to chronic doxorubicin treatment in male spontaneous hypertension-heart failure (SHHF), spontaneously hypertensive (SHR), and Wistar Kyoto (WKY) rats. Toxicol Appl Pharmacol. 2013;273(1):47\u201357.","journal-title":"Toxicol Appl Pharmacol"},{"key":"183_CR13","doi-asserted-by":"publisher","first-page":"8139861","DOI":"10.1155\/2016\/8139861","volume":"2016","author":"RK Kuriakose","year":"2016","unstructured":"Kuriakose RK, Kukreja RC, Xi L. Potential therapeutic strategies for hypertension-exacerbated cardiotoxicity of anticancer drugs. Oxidative Med Cell Longev. 2016;2016:8139861.","journal-title":"Oxidative Med Cell Longev"},{"issue":"6","key":"183_CR14","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1161\/CIRCRESAHA.115.305376","volume":"118","author":"S Menazza","year":"2016","unstructured":"Menazza S, Murphy E. The expanding complexity of estrogen receptor signaling in the cardiovascular system. Circ Res. 2016;118(6):994\u20131007.","journal-title":"Circ Res"},{"issue":"1","key":"183_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0008-6363(98)00076-5","volume":"39","author":"SA Doggrell","year":"1998","unstructured":"Doggrell SA, Brown L. Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res. 1998;39(1):89\u2013105.","journal-title":"Cardiovasc Res"},{"issue":"8","key":"183_CR16","doi-asserted-by":"publisher","first-page":"e70575","DOI":"10.1371\/journal.pone.0070575","volume":"8","author":"JS Dickey","year":"2013","unstructured":"Dickey JS, Gonzalez Y, Aryal B, Mog S, Nakamura AJ, Redon CE, Baxa U, Rosen E, Cheng G, Zielonka J, et al. Mito-tempol and dexrazoxane exhibit cardioprotective and chemotherapeutic effects through specific protein oxidation and autophagy in a syngeneic breast tumor preclinical model. PLoS One. 2013;8(8):e70575.","journal-title":"PLoS One"},{"issue":"1\u20133","key":"183_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ejphar.2005.08.056","volume":"523","author":"JR Munoz-Castaneda","year":"2005","unstructured":"Munoz-Castaneda JR, Montilla P, Munoz MC, Bujalance I, Muntane J, Tunez I. Effect of 17-beta-estradiol administration during adriamycin-induced cardiomyopathy in ovariectomized rat. Eur J Pharmacol. 2005;523(1\u20133):86\u201392.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"183_CR18","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00280-015-2786-8","volume":"76","author":"Y Gonzalez","year":"2015","unstructured":"Gonzalez Y, Pokrzywinski KL, Rosen ET, Mog S, Aryal B, Chehab LM, Vijay V, Moland CL, Desai VG, Dickey JS, et al. Reproductive hormone levels and differential mitochondria-related oxidative gene expression as potential mechanisms for gender differences in cardiosensitivity to doxorubicin in tumor-bearing spontaneously hypertensive rats. Cancer Chemother Pharmacol. 2015;76(3):447\u201359.","journal-title":"Cancer Chemother Pharmacol"},{"key":"183_CR19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jsbmb.2013.05.015","volume":"137","author":"JR Bell","year":"2013","unstructured":"Bell JR, Bernasochi GB, Varma U, Raaijmakers AJ, Delbridge LM. Sex and sex hormones in cardiac stress\u2014mechanistic insights. J Steroid Biochem Mol Biol. 2013;137:124\u201335.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"183_CR20","first-page":"353","volume":"59","author":"MD Ingegno","year":"1988","unstructured":"Ingegno MD, Money SR, Thelmo W, Greene GL, Davidian M, Jaffe BM, Pertschuk LP. Progesterone receptors in the human heart and great vessels. Lab Investig. 1988;59(3):353\u20136.","journal-title":"Lab Investig"},{"issue":"5","key":"183_CR21","doi-asserted-by":"publisher","first-page":"H1806","DOI":"10.1152\/ajpheart.00283.2009","volume":"297","author":"AM Deschamps","year":"2009","unstructured":"Deschamps AM, Murphy E. Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. Am J Physiol Heart Circ Physiol. 2009;297(5):H1806\u201313.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"183_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1046\/j.1525-1373.2000.22308.x","volume":"223","author":"AM Persky","year":"2000","unstructured":"Persky AM, Green PS, Stubley L, Howell CO, Zaulyanov L, Brazeau GA, Simpkins JW. Protective effect of estrogens against oxidative damage to heart and skeletal muscle in vivo and in vitro. Proc Soc Exp Biol Med. 2000;223(1):59\u201366.","journal-title":"Proc Soc Exp Biol Med"},{"issue":"5","key":"183_CR23","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1474-9726.2010.00619.x","volume":"9","author":"S Morrissy","year":"2010","unstructured":"Morrissy S, Xu B, Aguilar D, Zhang J, Chen QM. Inhibition of apoptosis by progesterone in cardiomyocytes. Aging Cell. 2010;9(5):799\u2013809.","journal-title":"Aging Cell"},{"issue":"19","key":"183_CR24","doi-asserted-by":"publisher","first-page":"13092","DOI":"10.1074\/jbc.M601984200","volume":"281","author":"Y Urata","year":"2006","unstructured":"Urata Y, Ihara Y, Murata H, Goto S, Koji T, Yodoi J, Inoue S, Kondo T. 17Beta-estradiol protects against oxidative stress-induced cell death through the glutathione\/glutaredoxin-dependent redox regulation of Akt in myocardiac H9c2 cells. J Biol Chem. 2006;281(19):13092\u2013102.","journal-title":"J Biol Chem"},{"issue":"5","key":"183_CR25","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.3892\/mmr.2017.6332","volume":"15","author":"XJ Zhang","year":"2017","unstructured":"Zhang XJ, Cao XQ, Zhang CS, Zhao Z. 17beta-estradiol protects against doxorubicin-induced cardiotoxicity in male Sprague-Dawley rats by regulating NADPH oxidase and apoptosis genes. Mol Med Rep. 2017;15(5):2695\u2013702.","journal-title":"Mol Med Rep"},{"issue":"2","key":"183_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1161\/CIRCRESAHA.108.190397","volume":"104","author":"C Donaldson","year":"2009","unstructured":"Donaldson C, Eder S, Baker C, Aronovitz MJ, Weiss AD, Hall-Porter M, Wang F, Ackerman A, Karas RH, Molkentin JD, et al. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation. Circ Res. 2009;104(2):265\u201375. 211p following 275","journal-title":"Circ Res"},{"issue":"1","key":"183_CR27","doi-asserted-by":"publisher","first-page":"e4655","DOI":"10.1590\/1414-431X20154655","volume":"49","author":"MV Borgo","year":"2016","unstructured":"Borgo MV, Claudio ER, Silva FB, Romero WG, Gouvea SA, Moyses MR, Santos RL, Almeida SA, Podratz PL, Graceli JB, et al. Hormonal therapy with estradiol and drospirenone improves endothelium-dependent vasodilation in the coronary bed of ovariectomized spontaneously hypertensive rats. Braz J Med Biol Res. 2016;49(1):e4655.","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"183_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1210\/endo-96-1-219","volume":"96","author":"MS Smith","year":"1975","unstructured":"Smith MS, Freeman ME, Neill JD. The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy. Endocrinology. 1975;96(1):219\u201326.","journal-title":"Endocrinology"},{"issue":"5","key":"183_CR29","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1530\/REP-06-0302","volume":"133","author":"GA Wood","year":"2007","unstructured":"Wood GA, Fata JE, Watson KL, Khokha R. Circulating hormones and estrous stage predict cellular and stromal remodeling in murine uterus. Reproduction. 2007;133(5):1035\u201344.","journal-title":"Reproduction"},{"issue":"4","key":"183_CR30","first-page":"274","volume":"26","author":"MA Emanuele","year":"2002","unstructured":"Emanuele MA, Wezeman F, Emanuele NV. Alcohol\u2019s effects on female reproductive function. Alcohol Res Health. 2002;26(4):274\u201381.","journal-title":"Alcohol Res Health"},{"key":"183_CR31","first-page":"Appendix 4I","volume":"Appendix 4","author":"CS Caligioni","year":"2009","unstructured":"Caligioni CS. Assessing reproductive status\/stages in mice. Curr Protoc Neurosci. 2009;Appendix 4:Appendix 4I.","journal-title":"Curr Protoc Neurosci"},{"issue":"3","key":"183_CR32","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1210\/endo.131.3.1505477","volume":"131","author":"DK Walmer","year":"1992","unstructured":"Walmer DK, Wrona MA, Hughes CL, Nelson KG. Lactoferrin expression in the mouse reproductive tract during the natural estrous cycle: correlation with circulating estradiol and progesterone. Endocrinology. 1992;131(3):1458\u201366.","journal-title":"Endocrinology"},{"issue":"3","key":"183_CR33","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1148\/radiol.2463070228","volume":"246","author":"B Weinberg","year":"2008","unstructured":"Weinberg B, Krupka T, Haaga J, Exner A. Combination of sensitizing pretreatment and radiofrequency tumor ablation: evaluation in rat model. Radiology. 2008;246(3):796\u2013803.","journal-title":"Radiology"},{"issue":"7","key":"183_CR34","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671\u20135.","journal-title":"Nat Methods"},{"key":"183_CR35","first-page":"e4389","volume":"67","author":"AC McLean","year":"2012","unstructured":"McLean AC, Valenzuela N, Fai S, Bennett SA. Performing vaginal lavage, crystal violet staining, and vaginal cytological evaluation for mouse estrous cycle staging identification. J Vis Exp. 2012;67:e4389.","journal-title":"J Vis Exp"},{"issue":"6","key":"183_CR36","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1177\/0192623315570339","volume":"43","author":"MC Cora","year":"2015","unstructured":"Cora MC, Kooistra L, Travlos G. Vaginal cytology of the laboratory rat and mouse: review and criteria for the staging of the estrous cycle using stained vaginal smears. Toxicol Pathol. 2015;43(6):776\u201393.","journal-title":"Toxicol Pathol"},{"issue":"6","key":"183_CR37","first-page":"865","volume":"62","author":"ME Billingham","year":"1978","unstructured":"Billingham ME, Mason JW, Bristow MR, Daniels JR. Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat Rep. 1978;62(6):865\u201372.","journal-title":"Cancer Treat Rep"},{"issue":"3","key":"183_CR38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00280-013-2227-5","volume":"72","author":"C Yoo","year":"2013","unstructured":"Yoo C, Yun MR, Ahn JH, Jung KH, Kim HJ, Kim JE, Park JY, Park KO, Yoon DH, Kim SB. Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort study. Cancer Chemother Pharmacol. 2013;72(3):565\u201375.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"183_CR39","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1080\/01480545.2017.1307851","volume":"41","author":"K Nishi","year":"2018","unstructured":"Nishi K, Gunasekaran VP, Arunachalam J, Ganeshan M. Doxorubicin-induced female reproductive toxicity: an assessment of ovarian follicular apoptosis, cyclicity and reproductive tissue histology in Wistar rats. Drug Chem Toxicol. 2018;41(1):72\u201381.","journal-title":"Drug Chem Toxicol"},{"issue":"4","key":"183_CR40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/humupd\/dmm009","volume":"13","author":"PG Groothuis","year":"2007","unstructured":"Groothuis PG, Dassen HH, Romano A, Punyadeera C. Estrogen and the endometrium: lessons learned from gene expression profiling in rodents and human. Hum Reprod Update. 2007;13(4):405\u201317.","journal-title":"Hum Reprod Update"},{"issue":"8","key":"183_CR41","doi-asserted-by":"publisher","first-page":"e445","DOI":"10.1016\/S1470-2045(17)30535-1","volume":"18","author":"BE Levis","year":"2017","unstructured":"Levis BE, Binkley PF, Shapiro CL. Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms? Lancet Oncol. 2017;18(8):e445\u201356.","journal-title":"Lancet Oncol"},{"issue":"4","key":"183_CR42","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s002800050048","volume":"45","author":"EH Herman","year":"2000","unstructured":"Herman EH, Zhang J, Chadwick DP, Ferrans VJ. Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats. Cancer Chemother Pharmacol. 2000;45(4):329\u201334.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"19","key":"183_CR43","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1001\/jama.2017.17488","volume":"318","author":"AR Chapman","year":"2017","unstructured":"Chapman AR, Lee KK, McAllister DA, Cullen L, Greenslade JH, Parsonage W, Worster A, Kavsak PA, Blankenberg S, Neumann J, et al. Association of high-sensitivity cardiac troponin I concentration with cardiac outcomes in patients with suspected acute coronary syndrome. JAMA. 2017;318(19):1913\u201324.","journal-title":"JAMA"},{"issue":"10","key":"183_CR44","doi-asserted-by":"publisher","first-page":"6760","DOI":"10.1074\/jbc.M511024200","volume":"281","author":"JK Kim","year":"2006","unstructured":"Kim JK, Pedram A, Razandi M, Levin ER. Estrogen prevents cardiomyocyte apoptosis through inhibition of reactive oxygen species and differential regulation of p38 kinase isoforms. J Biol Chem. 2006;281(10):6760\u20137.","journal-title":"J Biol Chem"},{"issue":"5","key":"183_CR45","doi-asserted-by":"publisher","first-page":"H1013","DOI":"10.1152\/ajpheart.00383.2017","volume":"313","author":"VM Miller","year":"2017","unstructured":"Miller VM, Harman SM. An update on hormone therapy in postmenopausal women: mini-review for the basic scientist. Am J Physiol Heart Circ Physiol. 2017;313(5):H1013\u201321.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"183_CR46","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1291\/hypres.31.1465","volume":"31","author":"MC Alvarez","year":"2008","unstructured":"Alvarez MC, Caldiz C, Fantinelli JC, Garciarena CD, Console GM, Chiappe de Cingolani GE, Mosca SM. Is cardiac hypertrophy in spontaneously hypertensive rats the cause or the consequence of oxidative stress? Hypertens Res. 2008;31(7):1465\u201376.","journal-title":"Hypertens Res"},{"key":"183_CR47","first-page":"794","volume":"52","author":"TP Devasagayam","year":"2004","unstructured":"Devasagayam TP, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD. Free radicals and antioxidants in human health: current status and future prospects. J Assoc Physicians India. 2004;52:794\u2013804.","journal-title":"J Assoc Physicians India"},{"issue":"6","key":"183_CR48","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3109\/0284186X.2016.1155738","volume":"55","author":"A Zavos","year":"2016","unstructured":"Zavos A, Valachis A. Risk of chemotherapy-induced amenorrhea in patients with breast cancer: a systematic review and meta-analysis. Acta Oncol. 2016;55(6):664\u201370.","journal-title":"Acta Oncol"},{"issue":"23","key":"183_CR49","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1001\/jama.2013.6461","volume":"309","author":"P Tehranifar","year":"2013","unstructured":"Tehranifar P, Akinyemiju TF, Terry MB. Incidence rate of breast cancer in young women. JAMA. 2013;309(23):2433\u20134.","journal-title":"JAMA"},{"issue":"3","key":"183_CR50","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321\u201333.","journal-title":"JAMA"},{"issue":"10","key":"183_CR51","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1093\/aje\/kwn044","volume":"167","author":"RL Prentice","year":"2008","unstructured":"Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Pettinger M, Hendrix SL, Hubbell FA, Kooperberg C, Kuller LH, Lane DS, et al. Estrogen plus progestin therapy and breast cancer in recently postmenopausal women. Am J Epidemiol. 2008;167(10):1207\u201316.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"183_CR52","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/sj.clpt.6100428","volume":"83","author":"JE Rossouw","year":"2008","unstructured":"Rossouw JE. Postmenopausal hormone therapy for disease prevention: have we learned any lessons from the past? Clin Pharmacol Ther. 2008;83(1):14\u20136.","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"183_CR53","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1158\/1055-9965.EPI-12-0759","volume":"21","author":"RH Mackey","year":"2012","unstructured":"Mackey RH, Fanelli TJ, Modugno F, Cauley JA, McTigue KM, Brooks MM, Chlebowski RT, Manson JE, Klug TL, Kip KE, et al. Hormone therapy, estrogen metabolism, and risk of breast cancer in the Women's Health Initiative hormone therapy trial. Cancer Epidemiol Biomark Prev. 2012;21(11):2022\u201332.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"8","key":"183_CR54","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0024-3205(00)00991-7","volume":"68","author":"MJ Moura","year":"2001","unstructured":"Moura MJ, Marcondes FK. Influence of estradiol and progesterone on the sensitivity of rat thoracic aorta to noradrenaline. Life Sci. 2001;68(8):881\u20138.","journal-title":"Life Sci"}],"container-title":["Biology of Sex Differences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-018-0183-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13293-018-0183-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-018-0183-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T13:56:55Z","timestamp":1589551015000},"score":1,"resource":{"primary":{"URL":"https:\/\/bsd.biomedcentral.com\/articles\/10.1186\/s13293-018-0183-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,15]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["183"],"URL":"https:\/\/doi.org\/10.1186\/s13293-018-0183-9","relation":{},"ISSN":["2042-6410"],"issn-type":[{"value":"2042-6410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,15]]},"assertion":[{"value":"21 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the United States Food and Drug Administration and the Department of Health and Human Services, nor does the mention of trade names, commercial products, or organizations imply endorsement by the United States Government.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 disclosures"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"25"}}